Anxu Biological: As of July 31, the total repurchased shares amounted to 24.3239 million yuan.

Anxu Bio announced that the company will implement a share repurchase plan on March 30, 2026, with an expected repurchase amount of 25-49 million yuan for the employee stock ownership plan or equity incentives, with the repurchase period ending on March 29, 2027. Due to the implementation of the 2025 annual equity distribution, the upper limit of the repurchase price has been adjusted to no more than 40.2 yuan per share. As of July 31, the company has cumulatively repurchased 671,939 shares, accounting for 0.5287% of the total equity, with funds paid amounting to 24.32 million yuan.